OP0258 IZOKIBEP (ABY-035) IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS – 16-WEEK RESULTS FROM A PHASE 2 STUDY

F. Behrens; P. C. Taylor; D. Wetzel; N. C. Brun; J. Brandt-Juergens; E. Drescher; E. Dokoupilova; A. Rowińska-Osuch; N. Abdel-Kader Martin; K. de Vlam

doi:10.1136/annrheumdis-2022-eular.536

Article info

PDF

Scientific Abstracts

Oral Presentations

Emerging treatment strategies in PsA

OP0258 IZOKIBEP (ABY-035) IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS – 16-WEEK RESULTS FROM A PHASE 2 STUDY

Free

Authors

F. Behrens University Hospital & Fraunhofer Institute for Translational Medicine and Pharmacology ITMP & Fraunhofer Cluster of Excellence for Immune-Mediated Disease CIMD, Rheumatology, Frankfurt, Germany PubMed articles Google scholar articles
P. C. Taylor University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom PubMed articles Google scholar articles
D. Wetzel Affibody AB, Clinical Development, Solna, Sweden PubMed articles Google scholar articles
N. C. Brun Affibody AB, Medical Science, Solna, Sweden PubMed articles Google scholar articles
J. Brandt-Juergens Partner Practice of Charité, Rheumatologische Schwerpunktpraxis, Berlin, Germany PubMed articles Google scholar articles
E. Drescher Vital Medical Center Privat Clinic, Rheumatology, Vesprém, Hungary PubMed articles Google scholar articles
E. Dokoupilova PubMed articles Google scholar articles
A. Rowińska-Osuch ETG Network, Rheumatology, Warsaw, Poland PubMed articles Google scholar articles
N. Abdel-Kader Martin Hospital Infanta Luisa Quiron, Rheumatology, Sevilla, Spain PubMed articles Google scholar articles
K. de Vlam University Hospitals Leuven, Rheumatology, Leuven, Belgium PubMed articles Google scholar articles

Citation

Behrens F, Taylor PC, Wetzel D, et al

OP0258 IZOKIBEP (ABY-035) IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS – 16-WEEK RESULTS FROM A PHASE 2 STUDY

Annals of the Rheumatic Diseases 2022;81:170-171.

Publication history

First published May 23, 2022.

Online issue publication

May 23, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password